190 related articles for article (PubMed ID: 11790169)
1. Efficacy of itraconazole in the prophylactic treatment of pityriasis (tinea) versicolor.
Faergemann J; Gupta AK; Al Mofadi A; Abanami A; Shareaah AA; Marynissen G
Arch Dermatol; 2002 Jan; 138(1):69-73. PubMed ID: 11790169
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Itraconazole in the Prevention of Recurrence of Tinea Versicolor: A Three Year Follow Up.
Wahab MA; Kamal SB; Shahin MR; Siddique RU; Hassan MR; Hassan BS; Kumar SB; Haque AR; Nandi AK; Das PK
Mymensingh Med J; 2020 Apr; 29(2):351-356. PubMed ID: 32506089
[TBL] [Abstract][Full Text] [Related]
3. Single dose (400 mg) versus 7 day (200 mg) daily dose itraconazole in the treatment of tinea versicolor: a randomized clinical trial.
Wahab MA; Ali ME; Rahman MH; Chowdhury SA; Monamie NS; Sultana N; Khondoker L
Mymensingh Med J; 2010 Jan; 19(1):72-6. PubMed ID: 20046175
[TBL] [Abstract][Full Text] [Related]
4. Itraconazole in the treatment of superficial mycoses--a double-blind study vs. placebo.
Roseeuw D; Willemsen M; Kint RT; Peremans W; Mertens RL; Van Cutsem J
Clin Exp Dermatol; 1990 Mar; 15(2):101-4. PubMed ID: 2161302
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of three short-term regimens of itraconazole in the treatment of pityriasis versicolor.
Kokturk A; Kaya TI; Ikizoglu G; Bugdayci R; Koca A
J Dermatolog Treat; 2002 Dec; 13(4):185-7. PubMed ID: 19753739
[TBL] [Abstract][Full Text] [Related]
6. Comparison of a single 400 mg dose versus a 7-day 200 mg daily dose of itraconazole in the treatment of tinea versicolor.
Köse O; Bülent Taştan H; Riza Gür A; Kurumlu Z
J Dermatolog Treat; 2002 Jun; 13(2):77-9. PubMed ID: 12060506
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, randomized, placebo-controlled evaluation of short-term treatment with oral itraconazole in patients with tinea versicolor.
Hickman JG
J Am Acad Dermatol; 1996 May; 34(5 Pt 1):785-7. PubMed ID: 8632075
[TBL] [Abstract][Full Text] [Related]
8. Treatment of dermatophytoses and pityriasis versicolor with itraconazole.
Panconesi E; Difonzo E
Rev Infect Dis; 1987; 9 Suppl 1():S109-13. PubMed ID: 3027833
[TBL] [Abstract][Full Text] [Related]
9. [Itraconazole in the treatment of pityriasis versicolor: comparison between 5 and 7 days of treatment].
Cucé LC; Belda Júnior W; Ribeiro EB
Rev Inst Med Trop Sao Paulo; 1990; 32(3):181-4. PubMed ID: 1966916
[TBL] [Abstract][Full Text] [Related]
10. Single-dose fluconazole versus itraconazole in pityriasis versicolor.
Partap R; Kaur I; Chakrabarti A; Kumar B
Dermatology; 2004; 208(1):55-9. PubMed ID: 14730238
[TBL] [Abstract][Full Text] [Related]
11. Itraconazole in pityriasis versicolor.
Estrada RA
Rev Infect Dis; 1987; 9 Suppl 1():S128-30. PubMed ID: 3027837
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, randomized, placebo-controlled, dose-finding study of oral pramiconazole in the treatment of pityriasis versicolor.
Faergemann J; Todd G; Pather S; Vawda ZF; Gillies JD; Walford T; Barranco C; Quiring JN; Briones M
J Am Acad Dermatol; 2009 Dec; 61(6):971-6. PubMed ID: 19828211
[TBL] [Abstract][Full Text] [Related]
13. Pityriasis versicolor: clinical experience with Lamisil cream and Lamisil DermGel.
Faergemann J; Hersle K; Nordin P
Dermatology; 1997; 194 Suppl 1():19-21. PubMed ID: 9154396
[TBL] [Abstract][Full Text] [Related]
14. A randomized double-blind, non-inferiority Phase II trial, comparing dapaconazole tosylate 2% cream with ketoconazole 2% cream in the treatment of Pityriasis versicolor.
Gobbato AA; Babadópulos T; Gobbato CA; Ilha Jde O; Gagliano-Jucá T; De Nucci G
Expert Opin Investig Drugs; 2015; 24(11):1399-407. PubMed ID: 26419668
[TBL] [Abstract][Full Text] [Related]
15. Pityriasis versicolor: efficacy of two five-day regimens of itraconazole.
Morales-Doria M
Rev Infect Dis; 1987; 9 Suppl 1():S131-3. PubMed ID: 3027838
[TBL] [Abstract][Full Text] [Related]
16. Treatment of pityriasis versicolor with itraconazole: a double-blind placebo controlled study.
Faergemann J
Mycoses; 1988 Jul; 31(7):377-9. PubMed ID: 2845267
[No Abstract] [Full Text] [Related]
17. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial.
Lange DS; Richards HM; Guarnieri J; Humeniuk JM; Savin RC; Reyes BA; Hickman J; Pariser DM; Pariser RJ; Sherertz EF; Grossman RM; Gisoldi EM; Klausner MA
J Am Acad Dermatol; 1998 Dec; 39(6):944-50. PubMed ID: 9843006
[TBL] [Abstract][Full Text] [Related]
18. Can pityriasis versicolor be treated with 2% ketoconazole foam?
Cantrell WC; Elewksi BE
J Drugs Dermatol; 2014 Jul; 13(7):855-9. PubMed ID: 25007370
[TBL] [Abstract][Full Text] [Related]
19. Itraconazole therapy in pityriasis versicolor.
del Palacio Hernanz A; Frias-Iniesta J; Gonzalez-Valle O; Borgers M; van Cutsem J; Cauwenbergh G
Br J Dermatol; 1986 Aug; 115(2):217-25. PubMed ID: 3017401
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of a topical application of terbinafine 1% solution in subjects with pityriasis versicolor: a placebo-controlled study.
Vermeer BJ; Staats CC
Dermatology; 1997; 194 Suppl 1():22-4. PubMed ID: 9154397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
